HAX1 and neoplasm: In addition, LY294002 also reversed the tumor-forming ability of uveal melanoma cells reduced by HAX-1 knockdown (Figure 6(e)), as well as the apoptosis of uveal melanoma cells induced by HAX-1 in the mitochondria-dependent pathway (Figure 6(f)).